Taiwan FDA registration 70ff77659cda3aaadc5a26bf08ef3327
Trinity Biotech glucose-6-phosphate dehydrogenase assay reagent
TW: 崔尼蒂生技葡萄糖-6-磷酸去氫酶檢驗試劑
Taiwan·Risk Class 2·TRINITY BIOTECH PLC·Registered Apr 11, 2012 – Apr 11, 2022CancelledRegistration details
- Analysis ID
- 70ff77659cda3aaadc5a26bf08ef3327
- Customs Code
- DHA00602344703
Company information
- Manufacturer
- TRINITY BIOTECH PLC
- Manufacturer Country
- Ireland
- Authorized Representative
- BioChain Co., Ltd.
Product details
- Intended Use
- Quantitative detection of glucose-6-phosphate dehydrogenase in blood at 340 nm by ultraviolet kinetics.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.7360 Analysis of glucose-6-phosphate hydrolytic enzyme in red blood cells
- Import Information
- import
Dates and status
- Registration Date
- Apr 11, 2012
- Expiry Date
- Apr 11, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Trinity Biotech glucose-6-phosphate dehydrogenase assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 70ff77659cda3aaadc5a26bf08ef3327 and manufactured by TRINITY BIOTECH PLC. The authorized representative in Taiwan is BioChain Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices